Evidence map›Paper›PMID 22230689›Full record

ArticleCellular signalling2012

Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells.

Brian M Barth, Sally J Gustafson, Jody L Hankins, James M Kaiser, Jeremy K Haakenson, Mark Kester, Thomas B Kuhn

Abstract read
In one paragraph

Article in Cellular signalling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Implication of Ceramide Kinase in Adipogenesis.Mediators of inflammation · 2017
    Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brian M BarthDepartment of Chemistry and Biochemistry, University of Alaska-Fairbanks, 900 Yukon Drive, Fairbanks, AK 99775, USA. bmb14@psu.edu
Sally J Gustafson
Jody L Hankins
James M Kaiser
Jeremy K Haakenson
Mark Kester
Thomas B Kuhn
Pennsylvania State University · USUniversity of Alaska Fairbanks · US

Funding

Rac-1 mediated superoxide signaling in neuronsU54NS041069 · NINDS · UNIVERSITY OF ALASKA FAIRBANKS · PI DUFFY, LAWRENCE K · 2000 to 2011
$14.1M
NINDS NIH HHS U54 NS041069NINDS NIH HHS U54 NS41069
6 · The paper itself

Abstract

A persistent inflammatory reaction is a hallmark of chronic and acute pathologies in the central nervous system (CNS) and greatly exacerbates neuronal degeneration. The proinflammatory cytokine tumor necrosis factor alpha (TNFα) plays a pivotal role in the initiation and progression of inflammatory processes provoking oxidative stress, eicosanoid biosynthesis, and the production of bioactive lipids. We established in neuronal cells that TNFα exposure dramatically increased Mg(2+)-dependent neutral sphingomyelinase (nSMase) activity thus generating the bioactive lipid mediator ceramide essential for subsequent NADPH oxidase (NOX) activation and oxidative stress. Since many of the pleiotropic effects of ceramide are attributable to its metabolites, we examined whether ceramide kinase (CerK), converting ceramide to ceramide-1-phosphate, is implicated both in NOX activation and enhanced eicosanoid production in neuronal cells. In the present study, we demonstrated that TNFα exposure of human SH-SY5Y neuroblastoma caused a profound increase in CerK activity. Depleting CerK activity using either siRNA or pharmacology completely negated NOX activation and eicosanoid biosynthesis yet, more importantly, rescued neuronal viability in the presence of TNFα. These findings provided evidence for a critical function of ceramide-1-phospate and thus CerK activity in directly linking sphingolipid metabolism to oxidative stress. This vital role of CerK in CNS inflammation could provide a novel therapeutic approach to intervene with the adverse consequences of a progressive CNS inflammation.

Indexed as

Cell Line, TumorCeramidesEicosanoidsHumansNADPH OxidasesNeuroblastomaOxidative StressPhosphotransferases (Alcohol Group Acceptor)Reactive Oxygen SpeciesTumor Necrosis Factor-alphaceramide 1-phosphateceramide kinaseCeramidesEicosanoidsNADPH OxidasesPhosphotransferases (Alcohol Group Acceptor)Reactive Oxygen SpeciesTumor Necrosis Factor-alpha

Identifiers

PMID22230689
PMCPMC3338860
OpenAlexW2077435283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.